InnovationMore in Innovation→
FDA clears Alzheimer’s blood test for symptomatic adults 40 and older
Key Takeaways
- The FDA cleared PrecivityAD2 for symptomatic adults aged 40 and older.
- The test analyzes amyloid and tau blood biomarkers and classifies results into three categories.
- A cited validation study reported strong performance in 1,142 symptomatic adults.
- The approval adds to a fast-growing class of FDA-cleared Alzheimer’s blood tests.
DE
DT Editorial Team··via newatlas.com
